Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Dutasteride mesotherapy helps treat male hair loss but may harm sperm and sexual function.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

Severe COVID-19 often leads to hair loss in India.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Baricitinib is effective and safe for treating severe alopecia areata.

The ProScope HR is an effective, user-friendly, and affordable tool for diagnosing hair loss.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

AB+ blood group is more common in alopecia areata patients.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.